Dr Rory O’Connor

Dr Rory O’Connor entered the pharmaceutical industry in 1989 designing and executing Phase 2/3 studies in Europe, following a career in medical practice. He joined Pfizer Clinical Development in 1994, working in neuroscience with responsibility for antipsychotic and neuroprotective agents. In 1996 he moved to Pfizer HQ in New York as Medical Director Neuroscience, leading the strategic development and launch of a novel antipsychotic, including direction of the associated global Phase 3b/4 clinical program.

In 2000 he assumed responsibility for Medical Affairs for Pfizer’s European operations, and has since held medical positions of increasing responsibility, including oversight of clinical operations and regulatory affairs.

He is currently Senior Vice-President and Chief Medical Officer for Internal Medicine, Pfizer Innovative Health, with responsibility for colleagues operating in over 100 countries. His interests include development and augmentation of medical colleagues’ skills and capabilities and the use of information technology to enhance effective and responsible relationships with healthcare providers.

Rory qualified in Medicine from the University of Liverpool in 1978 and practiced initially in internal and family medicine. He is a Fellow of the Faculty of Pharmaceutical Medicine of the Royal College of Physicians (UK).